Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of [Azilect] Rasagiline in Levodopa-treated Parkinson's Patients With Motor Fluctuations in Korea

Trial Profile

Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of [Azilect] Rasagiline in Levodopa-treated Parkinson's Patients With Motor Fluctuations in Korea

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Dec 2013

At a glance

  • Drugs Rasagiline (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jun 2012 Actual patient number is 132 as reported by ClinicalTrials.gov.
    • 29 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Apr 2012 Planned number of patients changed from 150 to 130 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top